[1] |
中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南(2014版)[J].中华皮肤科杂志, 2014, 47(7): 514⁃516. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.07.019.
|
[2] |
Powell RJ, Leech SC, Till S, et al. BSACI guideline for the management of chronic urticaria and angioedema[J]. Clin Exp Allergy, 2015, 45(3): 547⁃565. DOI: 10.1111/cea.12494.
|
[3] |
Zuberbier T, Aberer W, Asero R, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria[J]. Allergy, 2014, 69(7): e1⁃29. DOI: 10.1111/all.12370.
|
[4] |
Pite H, Wedi B, Borrego LM, et al. Management of childhood urticaria: current knowledge and practical recommendations[J]. Acta Derm Venereol, 2013, 93(5): 500⁃508. DOI: 10.2340/00015555⁃1573.
|
[5] |
闫毅, 刘瑞珍, 徐德钢. 枸地氯雷他定与依匹斯汀治疗慢性荨麻疹随机对照研究[J].中华皮肤科杂志, 2015, 48(1): 54⁃56. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.01.019.
|
[6] |
Salmun LM, Herron JM, Banfield C, et al. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years[J]. Clin Ther, 2000, 22(5): 613⁃621. DOI: 10.1016/S0149⁃2918(00)80048⁃X.
|
[7] |
李垣君, 陈谨萍, 张金桃, 等. 复方甘草酸苷片联合氯雷他定治疗儿童慢性荨麻疹的疗效观察[J].中国麻风皮肤病杂志, 2007, 23(6): 479⁃481. DOI: 10.3969/j.issn.1009⁃1157.2007.06. 008.
|
[8] |
程颖, 丁丽凤. 氯雷他定联合中药治疗小儿慢性荨麻疹30例临床观察[J]. 现代中西医结合杂志, 2010, 19(35): 4568⁃4569. DOI: 10.3969/j.issn.1008⁃8849.2010.35.032.
|
[9] |
徐文严. 地氯雷他定: 一种新的抗组胺药[J]. 中华皮肤科杂志, 2003, 36(11): 668⁃670. DOI: 10.3760/j.issn.0412⁃4030.2003. 11.036.
|
[10] |
Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children[J]. Curr Med Res Opin, 2004, 20(12): 1959⁃1965. DOI: 10.1185/030079904X14148.
|
[11] |
Gupta SK, Kantesaria B, Banfield C, et al. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults[J]. Br J Clin Pharmacol, 2007, 64(2): 174⁃184. DOI: 10.1111/j.1365⁃2125.2007.02859.x.
|